首页> 美国卫生研究院文献>British Heart Journal >Disopyramide stress test: a sensitive and specific tool for predicting impending high degree atrioventricular block in patients with bifascicular block.
【2h】

Disopyramide stress test: a sensitive and specific tool for predicting impending high degree atrioventricular block in patients with bifascicular block.

机译:Disopyramide压力测试:一种预测双房传导阻滞患者即将发生的高度房室传导阻滞的灵敏且特定的工具。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE--To study the value of intravenous disopyramide as part of an invasive electrophysiological study in predicting impending high degree atrioventricular block in patients with bifascicular block. DESIGN--An invasive electrophysiological study was performed in the basal state and after the infusion of disopyramide (2 mg/kg body weight). The progression to high degree atrioventricular block was assessed by bradycardia-detecting pacemakers or repeated 12-lead electrocardiogram recordings, or both. PATIENTS--73 patients with bifascicular block were included, of whom 25 had a history of unexplained syncope. The remaining 48 patients had no arrhythmia related symptoms and were included as controls. All patients had an ejection fraction of > 35%. RESULTS--After a mean follow up of 23 months, seven patients in the syncope group and three in the non-syncope group had a documented high degree atrioventricular block or pacemaker-detected bradycardia of < or = 30 beats/min for > or = 6 s. The sensitivity of the disopyramide test was 71% and the specificity 98%. The corresponding figures for an abnormal electrophysiological study in the basal state were 14% and 91%, respectively. CONCLUSIONS--The sensitivity of an invasive electrophysiological study in patients with bifascicular block and syncope can be markedly increased by the use of intravenous disopyramide. A positive test is a highly specific finding and warrants pacemaker implantation.
机译:目的-研究静脉二吡咯酰胺在有创电生理研究中的价值,以预测双丛性阻塞患者即将发生的高度房室传导阻滞。设计-在基础状态下和输注双吡酰胺(2 mg / kg体重)后进行了侵入性电生理研究。通过检测心动过缓的起搏器或重复的12导联心电图记录或两者来评估高度房室传导阻滞的进展。患者-包括73例双丛神经阻滞患者,其中25例有无法解释的晕厥病史。其余48例患者无心律失常相关症状,并作为对照组。所有患者的射血分数> 35%。结果-在平均随访23个月后,晕厥组中有7例患者,非晕厥组中有3例,有记录的高度房室传导阻滞或起搏器检测到的心动过缓<或= 30次/ min 6秒二吡酰胺试验的灵敏度为71%,特异性为98%。在基础状态下进行异常电生理研究的相应数字分别为14%和91%。结论-通过静脉注射二吡yr酰胺可以显着提高对双束传导阻滞和晕厥患者的侵入性电生理研究的敏感性。阳性测试是高度特异性的发现,需要植入起搏器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号